Metropolitan Life Insurance Company (MetLife)’s Accenture ACN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,289
| Closed | -$8.77M | – | 36 |
|
|
2024
Q1 | $8.77M | Sell |
25,289
-258
| -1% | -$94K | 0.38% | 41 |
|
|
2023
Q4 | $8.96M | Sell |
25,547
-552
| -2% | -$178K | 0.42% | 37 |
|
|
2023
Q3 | $8.02M | Sell |
26,099
-1,423
| -5% | -$448K | 0.42% | 37 |
|
|
2023
Q2 | $8.49M | Sell |
27,522
-646
| -2% | -$188K | 0.41% | 41 |
|
|
2023
Q1 | $8.05M | Sell |
28,168
-7,551
| -21% | -$2.06M | 0.41% | 41 |
|
|
2022
Q4 | $9.53M | Sell |
35,719
-1,165
| -3% | -$322K | 0.43% | 41 |
|
|
2022
Q3 | $9.49M | Sell |
36,884
-495
| -1% | -$143K | 0.45% | 40 |
|
|
2022
Q2 | $10.4M | Sell |
37,379
-854
| -2% | -$257K | 0.46% | 38 |
|
|
2022
Q1 | $12.9M | Sell |
38,233
-57,152
| -60% | -$19.3M | 0.46% | 38 |
|
|
2021
Q4 | $39.5M | Sell |
95,385
-2,620
| -3% | -$955K | 0.54% | 22 |
|
|
2021
Q3 | $31.4M | Sell |
98,005
-3,403
| -3% | -$1.11M | 0.45% | 30 |
|
|
2021
Q2 | $29.9M | Sell |
101,408
-9,625
| -9% | -$2.76M | 0.42% | 33 |
|
|
2021
Q1 | $30.7M | Sell |
111,033
-6,352
| -5% | -$1.64M | 0.46% | 32 |
|
|
2020
Q4 | $30.7M | Sell |
117,385
-4,914
| -4% | -$1.18M | 0.46% | 35 |
|
|
2020
Q3 | $27.6M | Sell |
122,299
-5,034
| -4% | -$1.15M | 0.47% | 37 |
|
|
2020
Q2 | $27.3M | Buy |
127,333
+3,033
| +2% | +$574K | 0.49% | 33 |
|
|
2020
Q1 | $20.3M | Sell |
124,300
-1,777
| -1% | -$342K | 0.42% | 43 |
|
|
2019
Q4 | $26.5M | Sell |
126,077
-1,255
| -1% | -$245K | 0.42% | 38 |
|
|
2019
Q3 | $24.5M | Sell |
127,332
-174
| -0.1% | -$33.7K | 0.42% | 39 |
|
|
2019
Q2 | $23.6M | Buy |
127,506
+5,677
| +5% | +$1.02M | 0.4% | 39 |
|
|
2019
Q1 | $21.4M | Sell |
121,829
-3,863
| -3% | -$607K | 0.39% | 43 |
|
|
2018
Q4 | $17.7M | Sell |
125,692
-690
| -0.5% | -$109K | 0.35% | 53 |
|
|
2018
Q3 | $21.5M | Sell |
126,382
-3,194
| -2% | -$532K | 0.36% | 49 |
|
|
2018
Q2 | $21.2M | Buy |
129,576
+5,995
| +5% | +$932K | 0.34% | 53 |
|
|
2018
Q1 | $19M | Buy |
123,581
+392
| +0.3% | +$62.1K | 0.27% | 58 |
|
|
2017
Q4 | $18.9M | Sell |
123,189
-196,649
| -61% | -$28.5M | 0.25% | 57 |
|
|
2017
Q3 | $43.2M | Sell |
319,838
-5,002
| -2% | -$652K | 0.27% | 61 |
|
|
2017
Q2 | $40.2M | Sell |
324,840
-6,914
| -2% | -$842K | 0.28% | 61 |
|
|
2017
Q1 | $39.8M | Sell |
331,754
-3,466
| -1% | -$414K | 0.28% | 63 |
|
|
2016
Q4 | $39.3M | Sell |
335,220
-10,466
| -3% | -$1.24M | 0.28% | 62 |
|
|
2016
Q3 | $42.2M | Sell |
345,686
-4,918
| -1% | -$560K | 0.31% | 56 |
|
|
2016
Q2 | $39.7M | Buy |
+350,604
| New | +$40.7M | 0.29% | 61 |
|
|
2014
Q3 | – | Sell |
-388,138
| Closed | -$31.6M | – | 2658 |
|
|
2014
Q2 | $31.6M | Sell |
388,138
-20,932
| -5% | -$1.68M | 0.22% | 94 |
|
|
2014
Q1 | $32.6M | Sell |
409,070
-5,382
| -1% | -$442K | 0.23% | 91 |
|
|
2013
Q4 | $34.1M | Sell |
414,452
-12,518
| -3% | -$947K | 0.24% | 83 |
|
|
2013
Q3 | $31.4M | Sell |
426,970
-6,508
| -2% | -$482K | 0.24% | 83 |
|
|
2013
Q2 | $31.2M | Buy |
+433,478
| New | +$34.4M | 0.25% | 80 |
|
Other funds holding ACN
Metropolitan Life Insurance Company (MetLife)'s ACN Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Accenture (ACN) in Q2 2024, closing a stake of 25,289 shares — an estimated $8.77M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ACN in Q2 2013 and held it in 37 quarters. The position peaked at $43.2M in Q3 2017. 2,302 funds tracked by Wall St. Rank hold ACN as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Accenture position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 25,289 Accenture shares in Q2 2024, an estimated $8.77M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Accenture in Q2 2013 and held it in 37 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Accenture position peaked at $43.2M in Q3 2017.
- 2,302 funds tracked by Wall St. Rank held Accenture as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.